PRULIFLOXACIN

SynDRA canonical compound SYN0004857 — structure-anchored drug synonym record

Clinical phase	Launched
Mechanism of action	bacterial DNA gyrase inhibitor
Indication	bronchitis \| diarrhea \| urinary tract infections
Disease area	gastroenterology \| infectious disease \| pulmonary

All known targets

NM441
Prulifloxacine
Prulifloxacino
Pruvel
NM-441
NSC-759833
Sword
Prulifloxacin (hydrochloride)
6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
NCGC00164615-01
Quisnon
DSSTox_CID_26480
DSSTox_RID_81651
DSSTox_GSID_46480
1H,4H-(1,3)Thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-
1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-
6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
Prulifloxacin [INN]
6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
CCRIS 7686
CAS-123447-62-1
Pufloxacin dioxolil
6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
MLS006011767
CHEMBL422648
NAD-441A
OPT-99
SCHEMBL1650794
DTXSID0046480
CHEBI:32071
AOB5600
BCP12727
HY-B0024
Tox21_112235
BBL034010
MFCD00864847
s2071
STK626148